Philips
383 hedge funds and large institutions have $3.71B invested in Philips in 2021 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 127 increasing their positions, 210 reducing their positions, and 36 closing their positions.
46% more call options, than puts
Call options by funds: $26M | Put options by funds: $17.8M
25% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 36
2% more funds holding
Funds holding: 376 → 383 (+7)
0.25% more ownership
Funds ownership: 9.61% → 9.86% (+0.25%)
9% less capital invested
Capital invested by funds: $4.06B → $3.71B (-$347M)
40% less repeat investments, than reductions
Existing positions increased: 127 | Existing positions reduced: 210
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$220M |
| 2 |
BlackRock
New York
|
-$25.3M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$17.9M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$12.3M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$9.23M |
PHG Hedge Fund Activity: Q2 2021 in Review
383 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Philips (PHG) for Q2 2021, worth a combined $3.71B — down 8.5% from $4.06B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new PHG positions and 36 closed out — a net gain of 9 holders — while 127 added to existing stakes and 210 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $171M. The largest seller was T. Rowe Price Associates, cutting an estimated $220M.
- 383 institutional investors held Philips (PHG) as of Q2 2021, up from 376 in Q1 2021.
- Funds reported $3.71B of Philips stock for Q2 2021, down 8.5% quarter-over-quarter.
- 45 funds opened new Philips positions in Q2 2021 and 36 closed out, a net change of +9 holders.
- The largest Philips buyer in Q2 2021 was Wellington Management Group, an estimated $171M added.
- The largest Philips seller in Q2 2021 was T. Rowe Price Associates, an estimated $220M sold.
Based on aggregated 13F filings for Q2 2021.